Authors
Latest:
Future Outlooks in the Treatment of Metastatic Colorectal CancerExperts discuss their vision for the future of colorectal cancer treatment and anticipated advancements in the field.
Latest:
Dr Lee on the Surgical Implications of Molecular Testing in NSCLCPaul Chinfai Lee, MD, discusses the role of surgeons in regard to molecular testing in non–small cell lung cancer.
Latest:
Dr. Sklavenitis-Pistofidis on Single-Cell Dissection of Immune Cells in Smoldering MyelomaRomanos Sklavenitis-Pistofidis, MD, discusses single-cell dissection of bone marrow and peripheral blood immune cells in smoldering multiple myeloma.
Latest:
Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited Researchers for 2024Dana-Farber Cancer Institute announced that 42 of its researchers have been named to the Highly Cited Researchers list of 2024.
Latest:
Avelumab Plus Cisplatin-Based Chemotherapy Yields High EFS and OS Rates in MIUCThe addition of avelumab to cisplatin-based chemotherapy led to high event-free survival and overall survival rates in patients with muscle-invasive urothelial carcinoma.
Latest:
Dr. Wei on the Potential Implications of the CompassHER2 RD Trial in HER2+ Breast CancerMei Wei, MD, discusses the potential clinical implications of the ongoing, phase 3 CompassHER2 RD trial in HER2-positive breast cancer.
Latest:
Why Oncologists Should Know More About Medical MarijuanaIncreasingly, patients are asking oncologists for guidance and recommendations for the use of medical marijuana. However, finding those answers is challenging because of the federal government.
Latest:
Now is the Time to Improve Diversity in Cancer Clinical TrialFewer African American and Hispanic patients participated in oncology trials from 2003 to 2016 than from 1996 to 2002.
Latest:
Dr. Evens on the Design of a Retrospective Analysis Evaluating Salvage Regimens in R/R Hodgkin LymphomaAndrew M. Evens, DO, MSc, discusses the design of a retrospective analysis evaluating in relapsed/refractory classic Hodgkin lymphoma.
Latest:
Dr Srour on the Ongoing Investigation of CAR T-Cell Therapy in Advanced RCCSamer A. Srour, MB ChB, MS, discusses the investigation of the allogeneic CAR T-cell therapy CTX131 in advanced clear cell renal cell carcinoma.
Latest:
Dr Gertz on the Investigation of Birtamimab in Mayo Stage IV AL AmyloidosisMorie A. Gertz, MD, discusses the rationale for the phase 3 AFFIRM-AL trial in patients with amyloid light chain amyloidosis and elaborates on the challenges that may arise when enrolling patients to this trial.
Latest:
Reviewing Best Practices in the Surgical Management of Breast Cancer: Post-Surgery Outcomes in Stage IV DiseaseIn this final episode of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, shed light on clinical outcomes following surgery of the primary tumor in patients with stage IV breast cancer.
Latest:
Dr Billè on the Use of Minimally Invasive Surgery vs Stereotactic Radiotherapy in NSCLCAndrea Billè, MD, discusses findings from a propensity-matched comparison of minimally invasive surgery vs stereotactic ablative radiotherapy in patients with clinical stage I non–small cell lung cancer.
Latest:
Women in Oncology: Leukemia Therapies in Humans, for HumansJudith Karp, MD, Azra Raza, MD, and Michelle M. Le Beau, PhD, discuss their proudest career accomplishments, including the investigation of potential treatments using a patient’s first cancerous cell, advances in cytogenetics, and a rational design for clinical trials involving cell cytokinetics..
Latest:
Dr. Azad on Selecting Between Regorafenib and TAS-102 in CRCNilofer Saba Azad, MD, discusses selecting between regorafenib and TAS-102 in colorectal cancer.
Latest:
Dr Punekar on the Evaluation of NT-112 in KRAS G12D+ Advanced Solid TumorsSalman R. Punekar, MD discusses the rationale for evaluating safety and preliminary anti-tumor activity of NT-112 in solid tumors with the KRAS G12D mutation.
Latest:
Dr Hughes on the Safety of Asciminib in Ph+ CP-CMLTimothy Hughes, MD, MBBS, FRACP, FRCPA, on safety data for asciminib in Philadelphia chromosome–positive chronic-phase chronic myeloid leukemia.
Latest:
Dr. Moyers on Real-World Data With Adjuvant Immunotherapy in MelanomaJustin Moyers, MD, discusses real-world data and sociodemographic factors from an early analysis of the National Cancer Database associated with the treatment of adjuvant immunotherapy in stage III melanoma.
Latest:
The Future of Ovarian Cancer TreatmentOncologists contemplate what ovarian cancer treatment will look like in the future and exciting clinical trials in progress.
Latest:
Dr. Gupta on the Use of Platinum Plus Standard Neoadjuvant Chemotherapy in TNBCSudeep Gupta, MBBS, professor, medical oncology, Tata Memorial Hospital, Mumbai, discusses key efficacy and safety data from a phase 3 trial of platinum plus standard neoadjuvant chemotherapy in operable, locally advanced triple-negative breast cancer.
Latest:
Dr Ged on the Background of the ORCHID Trial in BAP1-Mutated Metastatic RCCYasser Mohamed Ali Ged, MBBS, discusses the background of launching the phase 2 ORCHID trial evaluating olaparib monotherapy in patients with metastatic renal cell carcinoma harboring BAP1 or other DNA repair gene mutations.
Latest:
Future Perspectives in EGFR+ NSCLCGlobal perspectives on the future management of EGFR+ non–small cell lung cancer given recent advances in the treatment paradigm.
Latest:
Dr. Hwang on First-line Treatment Options in HCCJimmy Hwang, MD, discusses currently available first-line treatment options in hepatocellular carcinoma, and areas of continued unmet need in this space.
Latest:
Dr. Barata on Patient-Reported Toxicities With Axi-Cel at 1-Year of Follow-UpAnna Barata, PhD, discusses patient-reported toxicities with axicabtagene ciloleucel (axi-cel) in patients 1-year post-infusion.
Latest:
Future of R/R DLBCLA panel of experts discuss the future of R/R DLBCL treatment and review some recent data from the 2022 ASH meeting.
Latest:
Ongoing Research in GI CancersMohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
.jpg?fit=crop&auto=format)
